Selected research
Industry Growth & Trends
Global Injectable Drug Packaging Industry Growth and Trends Forecast to 2032
Market perspective
The global Injectable Drug Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Injectable Drug Packaging include Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland) and B. Braun Melsungen (Germany), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Injectable Drug Packaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Injectable Drug Packaging market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injectable Drug Packaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injectable Drug Packaging.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Injectable Drug Packaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Injectable Drug Packaging Market by Company
Becton,Dickinson and Company (U.S.)
Pfizer Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
Baxter International, Inc. (U.S.)
Schott AG (Germany)
Gerresheimer (Germany)
Ypsomed (Switzerland)
B. Braun Melsungen (Germany)
Injectable Drug Packaging Segment by Type
Ampules
Vials
Cartridges
Bottles
Injectable Drug Packaging Segment by Application
Hospitals & Clinics
Home Care Settings
Other Facilities of Use
Injectable Drug Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Drug Packaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Injectable Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ampules
- Vials
- Cartridges
- Bottles
Applications
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
Companies covered
- Becton,Dickinson and Company (U.S.)
- Pfizer Inc. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Eli Lilly and Company (U.S.)
- Baxter International, Inc. (U.S.)
- Schott AG (Germany)
- Gerresheimer (Germany)
- Ypsomed (Switzerland)
- B. Braun Melsungen (Germany)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Injectable Drug Packaging Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Injectable Drug Packaging Sales Estimates and Forecasts (2021-2032)
- 1.3 Injectable Drug Packaging Market by Type
- 1.3.1 Ampules
- 1.3.2 Vials
- 1.3.3 Cartridges
- 1.3.4 Bottles
- 1.4 Global Injectable Drug Packaging Market Size by Type
- 1.4.1 Global Injectable Drug Packaging Market Size Overview by Type (2021-2032)
- 1.4.2 Global Injectable Drug Packaging Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Injectable Drug Packaging Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Injectable Drug Packaging Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Injectable Drug Packaging Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Injectable Drug Packaging Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Injectable Drug Packaging Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Injectable Drug Packaging Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Injectable Drug Packaging Industry Trends
- 2.2 Injectable Drug Packaging Industry Drivers
- 2.3 Injectable Drug Packaging Industry Opportunities and Challenges
- 2.4 Injectable Drug Packaging Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Injectable Drug Packaging Revenue (2021-2026)
- 3.2 Global Top Players by Injectable Drug Packaging Sales (2021-2026)
- 3.3 Global Top Players by Injectable Drug Packaging Price (2021-2026)
- 3.4 Global Injectable Drug Packaging Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Injectable Drug Packaging Major Company Production Sites & Headquarters
- 3.6 Global Injectable Drug Packaging Company, Product Type & Application
- 3.7 Global Injectable Drug Packaging Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Injectable Drug Packaging Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Injectable Drug Packaging Players Market Share by Revenue in 2025
- 3.8.3 2025 Injectable Drug Packaging Tier 1, Tier 2, and Tier 3
4 Injectable Drug Packaging Regional Status and Outlook
- 4.1 Global Injectable Drug Packaging Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Injectable Drug Packaging Historic Market Size by Region
- 4.2.1 Global Injectable Drug Packaging Sales in Volume by Region (2021-2026)
- 4.2.2 Global Injectable Drug Packaging Sales in Value by Region (2021-2026)
- 4.2.3 Global Injectable Drug Packaging Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Injectable Drug Packaging Forecasted Market Size by Region
- 4.3.1 Global Injectable Drug Packaging Sales in Volume by Region (2027-2032)
- 4.3.2 Global Injectable Drug Packaging Sales in Value by Region (2027-2032)
- 4.3.3 Global Injectable Drug Packaging Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injectable Drug Packaging by Application
- 5.1 Injectable Drug Packaging Market by Application
- 5.1.1 Hospitals & Clinics
- 5.1.2 Home Care Settings
- 5.1.3 Other Facilities of Use
- 5.2 Global Injectable Drug Packaging Market Size by Application
- 5.2.1 Global Injectable Drug Packaging Market Size Overview by Application (2021-2032)
- 5.2.2 Global Injectable Drug Packaging Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Injectable Drug Packaging Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Injectable Drug Packaging Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Injectable Drug Packaging Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Injectable Drug Packaging Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Injectable Drug Packaging Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Injectable Drug Packaging Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Becton,Dickinson and Company (U.S.)
- 6.1.1 Becton,Dickinson and Company (U.S.) Company Information
- 6.1.2 Becton,Dickinson and Company (U.S.) Business Overview
- 6.1.3 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio
- 6.1.5 Becton,Dickinson and Company (U.S.) Recent Developments
- 6.2 Pfizer Inc. (U.S.)
- 6.2.1 Pfizer Inc. (U.S.) Company Information
- 6.2.2 Pfizer Inc. (U.S.) Business Overview
- 6.2.3 Pfizer Inc. (U.S.) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio
- 6.2.5 Pfizer Inc. (U.S.) Recent Developments
- 6.3 Teva Pharmaceuticals Industries Ltd. (Israel)
- 6.3.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Information
- 6.3.2 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
- 6.3.3 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio
- 6.3.5 Teva Pharmaceuticals Industries Ltd. (Israel) Recent Developments
- 6.4 Eli Lilly and Company (U.S.)
- 6.4.1 Eli Lilly and Company (U.S.) Company Information
- 6.4.2 Eli Lilly and Company (U.S.) Business Overview
- 6.4.3 Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio
- 6.4.5 Eli Lilly and Company (U.S.) Recent Developments
- 6.5 Baxter International, Inc. (U.S.)
- 6.5.1 Baxter International, Inc. (U.S.) Company Information
- 6.5.2 Baxter International, Inc. (U.S.) Business Overview
- 6.5.3 Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio
- 6.5.5 Baxter International, Inc. (U.S.) Recent Developments
- 6.6 Schott AG (Germany)
- 6.6.1 Schott AG (Germany) Company Information
- 6.6.2 Schott AG (Germany) Business Overview
- 6.6.3 Schott AG (Germany) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Schott AG (Germany) Injectable Drug Packaging Product Portfolio
- 6.6.5 Schott AG (Germany) Recent Developments
- 6.7 Gerresheimer (Germany)
- 6.7.1 Gerresheimer (Germany) Company Information
- 6.7.2 Gerresheimer (Germany) Business Overview
- 6.7.3 Gerresheimer (Germany) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio
- 6.7.5 Gerresheimer (Germany) Recent Developments
- 6.8 Ypsomed (Switzerland)
- 6.8.1 Ypsomed (Switzerland) Company Information
- 6.8.2 Ypsomed (Switzerland) Business Overview
- 6.8.3 Ypsomed (Switzerland) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio
- 6.8.5 Ypsomed (Switzerland) Recent Developments
- 6.9 B. Braun Melsungen (Germany)
- 6.9.1 B. Braun Melsungen (Germany) Company Information
- 6.9.2 B. Braun Melsungen (Germany) Business Overview
- 6.9.3 B. Braun Melsungen (Germany) Injectable Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio
- 6.9.5 B. Braun Melsungen (Germany) Recent Developments
7 North America by Country
- 7.1 North America Injectable Drug Packaging Sales by Country
- 7.1.1 North America Injectable Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Injectable Drug Packaging Sales by Country (2021-2026)
- 7.1.3 North America Injectable Drug Packaging Sales Forecast by Country (2027-2032)
- 7.2 North America Injectable Drug Packaging Market Size by Country
- 7.2.1 North America Injectable Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Injectable Drug Packaging Market Size by Country (2021-2026)
- 7.2.3 North America Injectable Drug Packaging Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Injectable Drug Packaging Sales by Country
- 8.1.1 Europe Injectable Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Injectable Drug Packaging Sales by Country (2021-2026)
- 8.1.3 Europe Injectable Drug Packaging Sales Forecast by Country (2027-2032)
- 8.2 Europe Injectable Drug Packaging Market Size by Country
- 8.2.1 Europe Injectable Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Injectable Drug Packaging Market Size by Country (2021-2026)
- 8.2.3 Europe Injectable Drug Packaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Injectable Drug Packaging Sales by Country
- 9.1.1 Asia-Pacific Injectable Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Injectable Drug Packaging Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Injectable Drug Packaging Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Injectable Drug Packaging Market Size by Country
- 9.2.1 Asia-Pacific Injectable Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Injectable Drug Packaging Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Injectable Drug Packaging Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Injectable Drug Packaging Sales by Country
- 10.1.1 South America Injectable Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Injectable Drug Packaging Sales by Country (2021-2026)
- 10.1.3 South America Injectable Drug Packaging Sales Forecast by Country (2027-2032)
- 10.2 South America Injectable Drug Packaging Market Size by Country
- 10.2.1 South America Injectable Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Injectable Drug Packaging Market Size by Country (2021-2026)
- 10.2.3 South America Injectable Drug Packaging Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Injectable Drug Packaging Sales by Country
- 11.1.1 Middle East and Africa Injectable Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Injectable Drug Packaging Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Injectable Drug Packaging Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Injectable Drug Packaging Market Size by Country
- 11.2.1 Middle East and Africa Injectable Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Injectable Drug Packaging Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Injectable Drug Packaging Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Injectable Drug Packaging Value Chain Analysis
- 12.1.1 Injectable Drug Packaging Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Injectable Drug Packaging Production Mode & Process
- 12.2 Injectable Drug Packaging Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Injectable Drug Packaging Distributors
- 12.2.3 Injectable Drug Packaging Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst